Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Ischemic Heart Disease

  Free Subscription

Articles published in J Mol Cell Cardiol

Retrieve available abstracts of 64 articles:
HTML format

Single Articles

    September 2022
  1. HAPKE N, Heinrichs M, Ashour D, Vogel E, et al
    Identification of a novel cardiac epitope triggering T-cell responses in patients with myocardial infarction.
    J Mol Cell Cardiol. 2022 Sep 16. pii: S0022-2828(22)00520.
    PubMed     Abstract available

  2. QI L, Wang Y, Hu H, Li P, et al
    m(6)A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6/NF-kappaB pathway and ROS production.
    J Mol Cell Cardiol. 2022;170:87-99.
    PubMed     Abstract available

  3. ZHU W, Sun J, Bishop SP, Sadek H, et al
    Turning back the clock: A concise viewpoint of cardiomyocyte cell cycle activation for myocardial regeneration and repair.
    J Mol Cell Cardiol. 2022;170:15-21.
    PubMed     Abstract available

    August 2022
  4. LI Y, Li C, Liu Q, Wang L, et al
    Loss of Acta2 in cardiac fibroblasts does not prevent the myofibroblast differentiation or affect the cardiac repair after myocardial infarction.
    J Mol Cell Cardiol. 2022;171:117-132.
    PubMed     Abstract available

    July 2022
  5. FERRERO KM, Koch WJ
    GRK2 in cardiovascular disease and its potential as a therapeutic target.
    J Mol Cell Cardiol. 2022;172:14-23.
    PubMed     Abstract available

    June 2022
  6. EBERHARDT DR, Lee SH, Yin X, Balynas AM, et al
    EFHD1 ablation inhibits cardiac mitoflash activation and protects cardiomyocytes from ischemia.
    J Mol Cell Cardiol. 2022;167:1-14.
    PubMed     Abstract available

    May 2022
  7. KHANNA A, Ayan B, Undieh AA, Yang YP, et al
    Advances in three-dimensional bioprinted stem cell-based tissue engineering for cardiovascular regeneration.
    J Mol Cell Cardiol. 2022;169:13-27.
    PubMed     Abstract available

  8. CHENG G, Zhu D, Huang K, Caranasos TG, et al
    Minimally invasive delivery of a hydrogel-based exosome patch to prevent heart failure.
    J Mol Cell Cardiol. 2022 May 3. pii: S0022-2828(22)00085.
    PubMed     Abstract available

  9. CHEN BR, Wei TW, Tang CP, Sun JT, et al
    MNK2-eIF4E axis promotes cardiac repair in the infarcted mouse heart by activating cyclin D1.
    J Mol Cell Cardiol. 2022;166:91-106.
    PubMed     Abstract available

    April 2022
  10. MOTURI S, Ghosh-Choudhary SK, Finkel T
    Cardiovascular disease and the biology of aging.
    J Mol Cell Cardiol. 2022;167:109-117.
    PubMed     Abstract available

  11. KONG D, Yu Y
    Prostaglandin D2 signaling and cardiovascular homeostasis.
    J Mol Cell Cardiol. 2022;167:97-105.
    PubMed     Abstract available

  12. JAMAIYAR A, Juguilon C, Wan W, Richardson D, et al
    The essential role for endothelial cell sprouting in coronary collateral growth.
    J Mol Cell Cardiol. 2022;165:158-171.
    PubMed     Abstract available

    March 2022
  13. WANG YL, Bai L, Shi XR, Zhu H, et al
    Osteoblast MR deficiency protects against adverse ventricular remodeling after myocardial infarction.
    J Mol Cell Cardiol. 2022 Mar 18. pii: S0022-2828(22)00047.
    PubMed     Abstract available

    February 2022
  14. MIDGETT DE, Thorn SL, Ahn SS, Uman S, et al
    CineCT platform for in vivo and ex vivo measurement of 3D high resolution Lagrangian strains in the left ventricle following myocardial infarction and intramyocardial delivery of theranostic hydrogel.
    J Mol Cell Cardiol. 2022 Feb 25. pii: S0022-2828(22)00032.
    PubMed     Abstract available

    January 2022
  15. QIN Z, Gao L, Lin G, Zhu H, et al
    The nuclear receptor co-repressor 1 is a novel cardioprotective factor against acute myocardial ischemia-reperfusion injury.
    J Mol Cell Cardiol. 2022 Jan 23. pii: S0022-2828(22)00009.
    PubMed     Abstract available

    December 2021
  16. CHEN CL, Kang PT, Zhang L, Xiao K, et al
    Reperfusion mediates heme impairment with increased protein cysteine sulfonation of mitochondrial complex III in the post-ischemic heart.
    J Mol Cell Cardiol. 2021;161:23-38.
    PubMed     Abstract available

    November 2021
  17. ZHU Y, Woo YJ
    Photosynthetic symbiotic therapeutics - An innovative, effective treatment for ischemic cardiovascular diseases.
    J Mol Cell Cardiol. 2021 Nov 20. pii: S0022-2828(21)00222.
    PubMed     Abstract available

  18. LANTZ C, Becker A, Thorp EB
    Can polarization of macrophage metabolism enhance cardiac regeneration?
    J Mol Cell Cardiol. 2021;160:87-96.
    PubMed     Abstract available

    October 2021
  19. CAGGIANO LR, Holmes JW, Witzenburg CM
    Individual variability in animal-specific hemodynamic compensation following myocardial infarction.
    J Mol Cell Cardiol. 2021 Oct 28. pii: S0022-2828(21)00207.
    PubMed     Abstract available

  20. PALIOURA D, Lazou A, Drosatos K
    Kruppel-like factor (KLF)5: An emerging foe of cardiovascular health.
    J Mol Cell Cardiol. 2021 Oct 12. pii: S0022-2828(21)00193.
    PubMed     Abstract available

  21. JEZEK F, Randall EB, Carlson BE, Beard DA, et al
    Systems analysis of the mechanisms governing the cardiovascular response to changes in posture and in peripheral demand during exercise.
    J Mol Cell Cardiol. 2021 Oct 6. pii: S0022-2828(21)00191.
    PubMed     Abstract available

  22. WANG X, Wan TC, Lauth A, Purdy AL, et al
    Conditional depletion of the acetyltransferase Tip60 protects against the damaging effects of myocardial infarction.
    J Mol Cell Cardiol. 2021 Oct 2. pii: S0022-2828(21)00189.
    PubMed     Abstract available

  23. CHEN G, Phan V, Luo X, Cao DJ, et al
    The mechanistic target of rapamycin complex 1 critically regulates the function of mononuclear phagocytes and promotes cardiac remodeling in acute ischemia.
    J Mol Cell Cardiol. 2021;159:62-79.
    PubMed     Abstract available

    September 2021
  24. KOELWYN GJ, Aboumsallem JP, Moore KJ, de Boer RA, et al
    Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis.
    J Mol Cell Cardiol. 2021 Sep 25. pii: S0022-2828(21)00180.
    PubMed     Abstract available

  25. HSU WT, Tseng YH, Jui HY, Kuo CC, et al
    5-Methoxytryptophan attenuates postinfarct cardiac injury by controlling oxidative stress and immune activation.
    J Mol Cell Cardiol. 2021;158:101-114.
    PubMed     Abstract available

  26. BIAN Y, Pang P, Li X, Yu S, et al
    CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart.
    J Mol Cell Cardiol. 2021;158:128-139.
    PubMed     Abstract available

    August 2021
  27. ZHU D, Wang Y, Thomas M, McLaughlin K, et al
    Exosomes from adipose-derived stem cells alleviate myocardial infarction via microRNA-31/FIH1/HIF-1alpha pathway.
    J Mol Cell Cardiol. 2021 Aug 30. pii: S0022-2828(21)00169.
    PubMed     Abstract available

  28. BAYER AL, Alcaide P
    MyD88: At the heart of inflammatory signaling and cardiovascular disease.
    J Mol Cell Cardiol. 2021 Aug 6. pii: S0022-2828(21)00154.
    PubMed     Abstract available

    July 2021
  29. ZHU H, Ivanovic M, Nguyen A, Nguyen PK, et al
    Immune checkpoint inhibitor cardiotoxicity: Breaking barriers in the cardiovascular immune landscape.
    J Mol Cell Cardiol. 2021 Jul 22. pii: S0022-2828(21)00147.
    PubMed     Abstract available

  30. VLACHOGIANNIS NI, Sachse M, Georgiopoulos G, Zormpas E, et al
    Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease.
    J Mol Cell Cardiol. 2021;160:111-120.
    PubMed     Abstract available

  31. MARNELL C, Bick A, Natarajan P
    Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
    J Mol Cell Cardiol. 2021 Jul 20. pii: S0022-2828(21)00145.
    PubMed     Abstract available

  32. CHO JY, Cowling RT
    5-Methoxytryptophan: A game changer in the management of post-myocardial infarction?
    J Mol Cell Cardiol. 2021 Jul 12. pii: S0022-2828(21)00142.

    June 2021
  33. KUBOTA A, Suto A, Suga K, Iwata A, et al
    Inhibition of Interleukin-21 prolongs the survival through the promotion of wound healing after myocardial infarction.
    J Mol Cell Cardiol. 2021;159:48-61.
    PubMed     Abstract available

  34. PATEREK A, Okninska M, Chajduk E, Polkowska-Motrenko H, et al
    Systemic iron deficiency does not affect the cardiac iron content and progression of heart failure.
    J Mol Cell Cardiol. 2021;159:16-27.
    PubMed     Abstract available

  35. WANG X, Lupton C, Lauth A, Wan TC, et al
    Evidence that the acetyltransferase Tip60 induces the DNA damage response and cell-cycle arrest in neonatal cardiomyocytes.
    J Mol Cell Cardiol. 2021;155:88-98.
    PubMed     Abstract available

    May 2021
  36. KOVALIK JP, Zhao X, Gao F, Leng S, et al
    Amino acid differences between diabetic older adults and non-diabetic older adults and their associations with cardiovascular function.
    J Mol Cell Cardiol. 2021 May 22. pii: S0022-2828(21)00103.
    PubMed     Abstract available

  37. MOUTON AJ, Flynn ER, Moak SP, Aitken NM, et al
    Dimethyl fumarate preserves left ventricular infarct integrity following myocardial infarction via modulation of cardiac macrophage and fibroblast oxidative metabolism.
    J Mol Cell Cardiol. 2021;158:38-48.
    PubMed     Abstract available

  38. SWEAAD WK, Stefanizzi FM, Chamorro-Jorganes A, Devaux Y, et al
    Relevance of N6-methyladenosine regulators for transcriptome: Implications for development and the cardiovascular system.
    J Mol Cell Cardiol. 2021 May 12. pii: S0022-2828(21)00100.
    PubMed     Abstract available

    April 2021
  39. CHEN X, Zhabyeyev P, Azad AK, Vanhaesebroeck B, et al
    Pharmacological and cell-specific genetic PI3Kalpha inhibition worsens cardiac remodeling after myocardial infarction.
    J Mol Cell Cardiol. 2021 Apr 19. pii: S0022-2828(21)00082.
    PubMed     Abstract available

  40. WAN R, Yuan P, Guo L, Shao J, et al
    Ubiquitin-like protein FAT10 suppresses SIRT1-mediated autophagy to protect against ischemic myocardial injury.
    J Mol Cell Cardiol. 2021;153:1-13.
    PubMed     Abstract available

    March 2021
  41. SUN X, Lyu L, Zhong X, Ni Z, et al
    Application of genetic cell-lineage tracing technology to study cardiovascular diseases.
    J Mol Cell Cardiol. 2021 Mar 18. pii: S0022-2828(21)00063.
    PubMed     Abstract available

  42. SCHIATTARELLA GG, Wang Y, Tian R, Hill JA, et al
    Metabolism and Inflammation in Cardiovascular Health and Diseases: Mechanismss to Therapies.
    J Mol Cell Cardiol. 2021 Mar 2. pii: S0022-2828(21)00045.

  43. HESSE M, Bednarz R, Carls E, Becker C, et al
    Proximity to injury, but neither number of nuclei nor ploidy define pathological adaptation and plasticity in cardiomyocytes.
    J Mol Cell Cardiol. 2021;152:95-104.
    PubMed     Abstract available

    February 2021
  44. NAKAYAMA Y, Mukai N, Wang BF, Yang K, et al
    Txnip C247S mutation protects the heart against acute myocardial infarction.
    J Mol Cell Cardiol. 2021 Feb 27. pii: S0022-2828(21)00048.
    PubMed     Abstract available

  45. MCCULLOCH A, Grandi E, Saucerman J
    Computational models of cardiovascular regulatory mechanisms.
    J Mol Cell Cardiol. 2021 Feb 26. pii: S0022-2828(21)00027.

  46. FISCHER MA, Vondriska TM
    Clinical epigenomics for cardiovascular disease: Diagnostics and therapies.
    J Mol Cell Cardiol. 2021 Feb 6. pii: S0022-2828(21)00028.
    PubMed     Abstract available

  47. KAYVANPOUR E, Gi WT, Sedaghat-Hamedani F, Lehmann DH, et al
    microRNA neural networks improve diagnosis of acute coronary syndrome (ACS).
    J Mol Cell Cardiol. 2021;151:155-162.
    PubMed     Abstract available

  48. XING W, Tan Y, Li K, Tian P, et al
    Upregulated hepatokine fetuin B aggravates myocardial ischemia/reperfusion injury through inhibiting insulin signaling in diabetic mice.
    J Mol Cell Cardiol. 2021;151:163-172.
    PubMed     Abstract available

    January 2021
  49. AGHAJANIAN A, Zhang H, Buckley BK, Wittchen ES, et al
    Decreased inspired oxygen stimulates de novo formation of coronary collaterals in adult heart.
    J Mol Cell Cardiol. 2021;150:1-11.
    PubMed     Abstract available

    December 2020
  50. LI Q, Taegtmeyer H, Wang ZV
    Diverse consequences of hexosamine biosynthesis in cardiovascular disease.
    J Mol Cell Cardiol. 2020 Dec 30. pii: S0022-2828(20)30362.

  51. HAMOUCHE W, Bisserier M, Brojakowska A, Eskandari A, et al
    Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19.
    J Mol Cell Cardiol. 2020 Dec 26. pii: S0022-2828(20)30349.
    PubMed     Abstract available

  52. ZHAO L, You T, Lu Y, Lin S, et al
    Elevated EZH2 in ischemic heart disease epigenetically mediates suppression of NaV1.5 expression.
    J Mol Cell Cardiol. 2020 Dec 25. pii: S0022-2828(20)30351.
    PubMed     Abstract available

  53. WANG J, Cheng X, Zhao H, Yang Q, et al
    Downregulation of the zinc transporter SLC39A13 (ZIP13) is responsible for the activation of CaMKII at reperfusion and leads to myocardial ischemia/reperfusion injury in mouse hearts.
    J Mol Cell Cardiol. 2020 Dec 8. pii: S0022-2828(20)30342.
    PubMed     Abstract available

    November 2020
  54. ROLLE IG, Crivellari I, Zanello A, Mazzega E, et al
    Heart failure impairs the mechanotransduction propeties of human cardiac pericytes.
    J Mol Cell Cardiol. 2020;151:15-30.
    PubMed     Abstract available

    October 2020
  55. WANG J, Zhang J, Lin X, Wang Y, et al
    DCA-TGR5 signaling activation alleviates inflammatory response and improves cardiac function in myocardial infarction.
    J Mol Cell Cardiol. 2020;151:3-14.
    PubMed     Abstract available

  56. RAZIN T, Melamed-Book N, Argaman J, Galin I, et al
    Interleukin-1alpha dependent survival of cardiac fibroblasts is associated with StAR/STARD1 expression and improved cardiac remodeling and function after myocardial infarction.
    J Mol Cell Cardiol. 2020 Oct 30. pii: S0022-2828(20)30314.
    PubMed     Abstract available

  57. TRIPATHI H, Al-Darraji A, Abo-Aly M, Peng H, et al
    Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction.
    J Mol Cell Cardiol. 2020 Oct 2. pii: S0022-2828(20)30291.
    PubMed     Abstract available

    Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus.
    J Mol Cell Cardiol. 2020;147:12-17.

    September 2020
  59. WANG S, Su X, Xu L, Chang C, et al
    Glycogen synthase kinase-3beta inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction.
    J Mol Cell Cardiol. 2020 Sep 26. pii: S0022-2828(20)30289.
    PubMed     Abstract available

  60. MISTRY P, Reitz CJ, Khatua TN, Rasouli M, et al
    Circadian influence on the microbiome improves heart failure outcomes.
    J Mol Cell Cardiol. 2020 Sep 19. pii: S0022-2828(20)30286.
    PubMed     Abstract available

    August 2020
  61. CHEN C, Li H, Hang W, Wang DW, et al
    Cardiac injuries in coronavirus disease 2019 (COVID-19).
    J Mol Cell Cardiol. 2020;145:25-29.
    PubMed     Abstract available

    February 2020
  62. PAPANICOLAOU KN, Ashok D, Liu T, Bauer TM, et al
    Global knockout of ROMK potassium channel worsens cardiac ischemia-reperfusion injury but cardiomyocyte-specific knockout does not: Implications for the identity of mitoKATP.
    J Mol Cell Cardiol. 2020;139:176-189.
    PubMed     Abstract available

  63. HE Y, Zou P, Lu Y, Jia D, et al
    Osteoprotegerin promotes intimal hyperplasia and contributes to in-stent restenosis: Role of an alphaVbeta3/FAK dependent YAP pathway.
    J Mol Cell Cardiol. 2020;139:1-13.
    PubMed     Abstract available

    January 2020
  64. ALI HR, Michel CR, Lin YH, McKinsey TA, et al
    Defining decreased protein succinylation of failing human cardiac myofibrils in ischemic cardiomyopathy.
    J Mol Cell Cardiol. 2020;138:304-317.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.